Inside information, profit warning: Raisio lowers its guidance for 2026 and provides preliminary information on the financial development of the third quarter

Raisio lowered its 2026 guidance, citing weaker-than-expected sales toward year-end and higher-than-anticipated costs from its ongoing ERP project. It now expects net sales to remain at the 2025 level and comparable EBIT to match 2025 or decrease slightly.

Analysis

The key read-through is a weaker earnings-quality profile, not simply slower growth: soft sales reduce operating leverage while ERP overruns add execution risk. The combination raises the chance that estimates remain vulnerable even if the revised full-year range is met. The release does not establish whether ERP costs are expensed, capitalized, or largely temporary; check cash-flow impact and the next update on implementation milestones before extrapolating the EBIT pressure.

Near term, RAIVV may face estimate revisions and a risk premium for forecast reliability, but the size of any move depends on the prior guidance and market expectations—neither is supplied. Over 1–3 months, watch sales trends and whether costs continue to migrate above plan. Over 6–18 months, a successful ERP rollout could improve operating processes; further delays or overruns would instead prolong cost and execution uncertainty. A recovery in sales or clear evidence that overruns are non-recurring would weaken the cautious thesis.

Contrarian angle: a guidance reset can remove some uncertainty, and this alone is not enough to justify an aggressive short without valuation, consensus, and price-action context. The more defensible stance is to demand evidence of stabilization before adding exposure.

Key Decisions for Investors

• For existing RAIVV holders, consider trimming or keeping exposure below target until the company demonstrates sales stabilization and credible ERP cost control; avoid treating the revised outlook as a confirmed earnings floor.
• Do not initiate a large outright short solely on this release. Reassess after price discovery and updated analyst estimates; a tactical underweight is preferable if the stock fails to stabilize and estimates continue moving down.
• Track quarterly sales, comparable EBIT, cash conversion, and ERP budget/timing disclosures. Persistent ERP overruns or further guidance reductions would strengthen the negative thesis; stable execution and sales recovery would invalidate it.
• Before sizing a directional trade, verify the previous guidance, consensus revisions, valuation, and ERP cost accounting and cash impact—these determine whether the news is already reflected in RAIVV.